BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 35804390)

  • 1. A signature of immune-related gene pairs (IRGPs) for risk stratification and prognosis of oral cancer patients.
    Yu Y; Tian J; Hou Y; Zhang X; Li L; Cong P; Ji L; Wang X
    World J Surg Oncol; 2022 Jul; 20(1):227. PubMed ID: 35804390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and Validation of an Individualized Immune Prognostic Signature for Recurrent Prostate Cancer.
    Jin Y; Wang L; Lou H; Song C; He X; Ding M
    Comb Chem High Throughput Screen; 2021; 24(1):98-108. PubMed ID: 32593277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A signature of 18 immune-related gene pairs to predict the prognosis of pancreatic cancer patients.
    Bu F; Nie H; Zhu X; Wu T; Lin K; Zhao J; Huang J
    Immun Inflamm Dis; 2020 Dec; 8(4):713-726. PubMed ID: 33128857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of immune gene pair-based signature predictive of prognosis and immunotherapy in esophageal cancer.
    Cao K; Ma T; Ling X; Liu M; Jiang X; Ma K; Zhu J; Ma J
    Ann Transl Med; 2021 Oct; 9(20):1591. PubMed ID: 34790797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a fourteen- innate immunity-related gene pairs signature for predicting prognosis head and neck squamous cell carcinoma.
    Zhang F; Liu Y; Yang Y; Yang K
    BMC Cancer; 2020 Oct; 20(1):1015. PubMed ID: 33081731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and Verification of an Immune-Related Gene Pairs Prognostic Signature in Hepatocellular Carcinoma.
    Feng X; Mu S; Ma Y; Wang W
    Front Mol Biosci; 2021; 8():715728. PubMed ID: 34660693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of an immune-related gene pairs signature for predicting clinical outcome in lung adenocarcinoma.
    Wu C; Hu Q; Ma D
    Sci Rep; 2021 Feb; 11(1):3611. PubMed ID: 33574499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and Validation of a Five-immune Gene Pair Signature in Endometrial Carcinoma.
    Li N; Yu K; Lin Z; Zeng D
    Comb Chem High Throughput Screen; 2021; 24(2):233-245. PubMed ID: 32729416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting the clinical outcome of melanoma using an immune-related gene pairs signature.
    Meng L; He X; Zhang X; Zhang X; Wei Y; Wu B; Li W; Li J; Xiao Y
    PLoS One; 2020; 15(10):e0240331. PubMed ID: 33031392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of prognostic gene signature associated with microenvironment of lung adenocarcinoma.
    Yue C; Ma H; Zhou Y
    PeerJ; 2019; 7():e8128. PubMed ID: 31803536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Immune-Related Gene Pairs Signature for Predicting Survival in Glioblastoma.
    Wang S; Xu X
    Front Oncol; 2021; 11():564960. PubMed ID: 33859933
    [No Abstract]   [Full Text] [Related]  

  • 12. Discovery and Verification of an Immune-Related Gene Pairs Signature for Predicting Prognosis in Head and Neck Squamous Cell Carcinoma.
    He J; Fang X; Han M
    Front Genet; 2021; 12():654657. PubMed ID: 34108990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Risk Score Signature Consisting of Six Immune Genes Predicts Overall Survival in Patients with Lower-Grade Gliomas.
    Wu Y; Peng Z; Gu S; Wang H; Xiang W
    Comput Math Methods Med; 2022; 2022():2558548. PubMed ID: 35186111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Immune-Related Gene Pairs Signature Predicts Prognosis and Immune Heterogeneity in Glioblastoma.
    Zhang N; Ge M; Jiang T; Peng X; Sun H; Qi X; Zou Z; Li D
    Front Oncol; 2021; 11():592211. PubMed ID: 33928021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A signature of 14 immune-related gene pairs predicts overall survival in gastric cancer.
    Zhao E; Zhou C; Chen S
    Clin Transl Oncol; 2021 Feb; 23(2):265-274. PubMed ID: 32519178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel immune-related gene pair prognostic signature for predicting overall survival in bladder cancer.
    Fu Y; Sun S; Bi J; Kong C; Yin L
    BMC Cancer; 2021 Jul; 21(1):810. PubMed ID: 34266411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and Validation of an Inflammatory Response-Related Gene Signature for Predicting the Prognosis of Pancreatic Adenocarcinoma.
    Deng ZL; Zhou DZ; Cao SJ; Li Q; Zhang JF; Xie H
    Inflammation; 2022 Aug; 45(4):1732-1751. PubMed ID: 35322324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A united risk model of 11 immune‑related gene pairs and clinical stage for prediction of overall survival in clear cell renal cell carcinoma patients.
    Tao Z; Zhang E; Li L; Zheng J; Zhao Y; Chen X
    Bioengineered; 2021 Dec; 12(1):4259-4277. PubMed ID: 34304692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction and Validation of a Novel Immune-Related Gene Pairs-Based Prognostic Model in Lung Adenocarcinoma.
    Liu Y; Zhou J; Wu J; Zhang X; Guo J; Xing Y; Xie J; Bai Y; Hu D
    Cancer Control; 2023; 30():10732748221150227. PubMed ID: 36625357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
    Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
    BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.